Safety and effectiveness of apixaban compared to warfarin in dialysis patients D Reed, S Palkimas, R Hockman, S Abraham, T Le, H Maitland Research and Practice in Thrombosis and Haemostasis 2 (2), 291-298, 2018 | 97 | 2018 |
Risk of major bleeding with ibrutinib J Mock, PR Kunk, S Palkimas, JM Sen, M Devitt, B Horton, CA Portell, ... Clinical Lymphoma Myeloma and Leukemia 18 (11), 755-761, 2018 | 66 | 2018 |
Direct oral anticoagulants in hypercoagulable states PR Kunk, J Brown, M McShane, S Palkimas, B Gail Macik Journal of thrombosis and thrombolysis 43, 79-85, 2017 | 39 | 2017 |
Major bleeding with ibrutinib: more than expected PR Kunk, J Mock, ME Devitt, S Palkimas, J Sen, CA Portell, ME Williams Blood 128 (22), 3229, 2016 | 30 | 2016 |
Antithrombin supplementation in adult patients receiving extracorporeal membrane oxygenation MJ Morrisette, A Zomp-Wiebe, KL Bidwell, SP Dunn, MG Gelvin, ... Perfusion 35 (1), 66-72, 2020 | 27 | 2020 |
Heparin-induced thrombocytopenia and cardiac surgery J Solanki, S Shenoy, E Downs, S Palkimas, S Goldman, AM Sharma Seminars in Thoracic and Cardiovascular Surgery 31 (3), 335-344, 2019 | 25 | 2019 |
Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome B Williams, JJ Saseen, T Trujillo, S Palkimas Journal of Thrombosis and Thrombolysis 54 (1), 67-73, 2022 | 22 | 2022 |
Use of direct oral anticoagulants in patients on immunomodulatory agents L Man, A Morris, J Brown, S Palkimas, K Davidson Journal of Thrombosis and Thrombolysis 44, 298-302, 2017 | 19 | 2017 |
Direct oral anticoagulants in patients with cirrhosis appear safe and effective PR Kunk, H Collins, S Palkimas, NM Intagliata, HS Maitland Blood 128 (22), 3827, 2016 | 18 | 2016 |
Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience T Tran, J Arnall, DC Moore, L Ward, S Palkimas, L Man Journal of thrombosis and thrombolysis 49, 431-440, 2020 | 17 | 2020 |
Safety and efficacy of direct oral anticoagulants in patients with moderate to severe cirrhosis M Oldham, S Palkimas, A Hedrick Annals of Pharmacotherapy 56 (7), 782-790, 2022 | 16 | 2022 |
Evaluation of the clinical impact of thromboprophylaxis in patients with COVID-19 following hospital discharge LA Courtney, TC Trujillo, JJ Saseen, G Wright, S Palkimas Annals of Pharmacotherapy 56 (9), 981-987, 2022 | 10 | 2022 |
Safety of doacs in patients of extreme weight L Talamo, HS Maitland, S Palkimas, D White Blood 128 (22), 1450, 2016 | 8 | 2016 |
A novel laboratory assay to monitor unfractionated heparin dosing in patients taking apixaban prior to hospital admission SW Strickland, S Palkimas, M Acker, LAL Bazydlo The Journal of Applied Laboratory Medicine 6 (2), 378-386, 2021 | 7 | 2021 |
The relationship between the initial anti‐factor Xa measurement and the duration of direct Oral anticoagulant influence in patients transitioning to heparin MD Plum, JN Hedrick, R Hockman, L Bazydlo, S Palkimas Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (9 …, 2020 | 6 | 2020 |
Evaluation of the use of argatroban or bivalirudin for the management of suspected heparin-induced thrombocytopenia in the setting of continuous renal replacement therapy T Chanas, S Palkimas, HS Maitland, A Liszewski Clinical Medicine Insights: Trauma and Intensive Medicine 10, 1179560319846452, 2019 | 6 | 2019 |
Decrease of asparaginase induced thrombotic events with antithrombin III monitoring and repletion K Grose, JM Sen, AL Morris, K DeGregory, S Palkimas, MG Douvas Blood 132, 1381, 2018 | 6 | 2018 |
Eptacog beta for bleeding treatment and prevention in congenital hemophilia a and B with inhibitors: a review of clinical data and implications for clinical practice AM Ciolek, J Arnall, DC Moore, S Palkimas, J Der-Nigoghossian, K Dane Annals of Pharmacotherapy 56 (7), 831-838, 2022 | 5 | 2022 |
Apixaban Therapy Is Safe And Effective In Most Organ Transplant Populations. A Brown, S Palkimas, W Ally AMERICAN JOURNAL OF TRANSPLANTATION 19, 1109-1110, 2019 | 3 | 2019 |
The sample that would not clot SW Strickland, E Burns, S Palkimas, LAL Bazydlo Clinica Chimica Acta 485, 272-274, 2018 | 3 | 2018 |